Journal of Healthcare Engineering / 2022 / Article / Tab 2 / Research Article
[Retracted] Study on Toll-Like Receptor 2-Mediated Inflammation-Induced Familial Hypertension Combined with Hyperlipemia and Its Mechanism Table 2 Sample baseline information: comparison of general data, disease history, and medication history of control group, familial hypertension group, and familial hypertension combined with hyperlipidemia group.
Baseline indicator Control group Familial hypertension Familial hypertension combined with hyperlipemia Natural properties Number of cases (n ) 22 25 19 Gender distribution (female cases/proportion (%)) 6 (27.27) 8 (32) 6 (31.58) 0.930 Age (years) 53.55 ± 15.02 52.92 ± 29.91 52.32 ± 21.12 0.701 Smoking history (positive cases/proportion (%)) 8 (36.36) 7 (28) 8 (42.10) 0.613 Disease history Diabetes mellitus 10 (45.45) 12 (48) 9 (47.37) 0.984 Type I diabetes mellitus 1 (4.54) 0 (0) 1 (5.26) 0.528 Type II diabetes mellitus 9 (40.9) 12 (48) 7 (36.84) 0.748 Hyperlipidemia 0 (0) 0 (0) 19 (100) <0.001 Atherosclerosis 19 (86.36) 22 (88) 16 (84.21) 0.936 Heart failure 1 (4.54) 0 (0) 1 (5.26) 0.528 Angina 2 (9.09) 2 (8) 2 (10.53) 0.959 Stable 0 (0) 1 (4) 0 (0) 0.435 Unstable 2 (9.09) 1 (4) 2 (10.53) 0.682 Myocardial infarction 10 (45.45) 11 (44) 10 (52.63) 0.838 STEMI 5 (22.73) 4 (16) 7 (36.84) 0.273 NSTEMI 5 (22.73) 7 (28) 5 (26.32) 0.916 Stroke 0 (0) 0 (0) 0 (0) 1.000 Drug use history Aspirin 12 (54.54) 10 (40) 10 (52.63) 0.556 Clopidogrel 10 (45.45) 10 (40) 9 (47.37) 0.874 Insulin 10 (45.45) 11 (44) 9 (47.37) 0.976 OHA 12 (54.54) 10 (40) 9 (47.37) 0.608 Statins 0 (0) 0 (0) 19 (100) <0.001 β -Receptor blocking pharmacon2 (9.09) 22 (88) 19 (100) <0.001 Diuretic 3 (13.64) 23 (92) 18 (94.7) <0.001 CCB 0 (0) 21 (84) 19 (100) <0.001 ACEI 2 (9.09) 20 (80 18 (94.7) <0.001 ARB 1 (4.54) 22 (88) 19 (100) <0.001 Blood pressure level Systolic pressure (mmHg) 129.82 ± 35.58 149.24 ± 94.023 155.42 ± 56.04 <0.001